Abound Wealth Management’s Glaukos GKOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$280 Sell
2
-1
-33% -$127 ﹤0.01% 1048
2026
Q1
$323 Hold
3
﹤0.01% 1116
2025
Q4
$339 Hold
3
﹤0.01% 1018
2025
Q3
$245 Hold
3
﹤0.01% 1060
2025
Q2
$310 Hold
3
﹤0.01% 914
2025
Q1
$296 Hold
3
﹤0.01% 874
2024
Q4
$450 Sell
3
-1
-25% -$138 ﹤0.01% 813
2024
Q3
$522 Sell
4
-2
-33% -$249 ﹤0.01% 870
2024
Q2
$711 Hold
6
﹤0.01% 764
2024
Q1
$566 Hold
6
﹤0.01% 856
2023
Q4
$477 Hold
6
﹤0.01% 935
2023
Q3
$452 Hold
6
﹤0.01% 836
2023
Q2
$428 Buy
+6
New +$344 ﹤0.01% 903

Other funds holding GKOS

Abound Wealth Management's GKOS Position: Q2 2026 in Review

Abound Wealth Management reduced its Glaukos (GKOS) stake by 33% in Q2 2026, selling an estimated $127 and leaving 2 shares worth $280. The position accounts for ﹤0.01% of the portfolio, ranked #1048.

Abound Wealth Management first reported a position in GKOS in Q2 2023 and has held it in 13 quarters since. The position peaked at $711 in Q2 2024. 365 funds tracked by Wall St. Rank hold GKOS as of Q2 2026.

  • Abound Wealth Management held 2 shares of Glaukos worth $280 as of Q2 2026.
  • Abound Wealth Management sold 1 Glaukos share in Q2 2026, an estimated $127.
  • Glaukos made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #1048 holding.
  • Abound Wealth Management first reported a position in Glaukos in Q2 2023 and has held it in 13 quarters since.
  • Abound Wealth Management's Glaukos position peaked at $711 in Q2 2024.
  • 365 funds tracked by Wall St. Rank held Glaukos as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.